15 Best Stocks Under $25 to Buy Now

Page 14 of 15

2. Pfizer Inc. (NYSE:PFE)

Share Price as of December 25: $25.00

Number of Hedge Fund Holders: 84

Pfizer Inc. (NYSE:PFE) ranks among the best stocks under $25 to buy now. Citing the company’s cautious 2026 outlook, BMO Capital reaffirmed its Outperform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on December 17. The pharmaceutical company anticipates adjusted profit to be between $2.80 and $3 per share in the upcoming year. In comparison to the updated 2025 sales forecast of $62 billion, Pfizer’s revenue is anticipated to be essentially flat, coming between $59.5 billion and $62.5 billion.

Pfizer Inc. (NYSE:PFE) also forecasted a $1.5 billion year-over-year reduction in sales when certain medications lost market exclusivity. Some blockbuster treatments, such as the company’s pneumonia vaccination Prevnar, are seeing stronger rivalry from competitors.

BMO observed that Pfizer’s softer 2026 projection is mostly driven by prolonged uncertainty in its Covid business, which is expected to fall 23% year-over-year to around $5 billion in total revenue.

BMO anticipates that future talks will center on Pfizer’s recent purchase of Metsera and the company’s efforts to deliver ongoing cost savings, which have already exceeded their 2025 projections.

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that manufactures, develops, markets, and sells biopharmaceutical products worldwide. It advances wellness, prevention, treatment, and cures in developing and emerging markets.

Page 14 of 15